ArticleFrontiers in neurology
Cerebrovascular phenotype analysis in
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Moyamoya disease (MMD) is characterized by progressive stenosis of the internal carotid artery and compensatory moyamoya angiogenesis. Although multiple studies have identified Methods: Intracranial arterial anatomy was assessed using 7.0T high‑resolution magnetic resonance angiography (MRA) and cerebral vascular casting. Vasoconstrictive remodeling was evaluated by calculating diameter ratios - specifically, internal carotid artery (ICA)/basilar artery (BA) and middle cerebral artery (MCA)/BA ratios. Histopathological evaluation was performed using hematoxylin and eosin (H&E) staining, elastic van Gieson (EVG) staining, and α‑smooth muscle actin (α‑SMA) immunohistochemistry to assess intracerebral macrovascular pathology. Cortical microvascular density and caliber were quantified using CD31 immunohistochemistry, while leptomeningeal vascular architecture was systematically analyzed using vascular casting, followed by skeletonization and topological analysis. Results: Conclusion: Under early adult (8-12 weeks) conditions,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.